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Abstract
A comparative analysis of the genomes of Drosophila melanogaster, Caenorhabditis elegans, and
Saccharomyces cerevisiae—and the proteins they are predicted to encode—was undertaken in the
context of cellular, developmental, and evolutionary processes. The nonredundant protein sets of
flies and worms are similar in size and are only twice that of yeast, but different gene families are
expanded in each genome, and the multidomain proteins and signaling pathways of the fly and worm
are far more complex than those of yeast. The fly has orthologs to 177 of the 289 human disease
genes examined and provides the foundation for rapid analysis of some of the basic processes
involved in human disease.
With the full genomic sequence of three major model organisms now available, much of our
knowledge about the evolutionary basis of cellular and developmental processes will derive
from comparisons between protein domains, intracellular networks, and cell-cell interactions
in different phyla. In this paper, we begin a comparison of D. melanogaster, C. elegans, and
S. cerevisiae. We first ask how many distinct protein families each genome encodes, how the
genes encoding these protein families are distributed in each genome, and how many genes
are shared among flies, worms, yeast, and mammals. Next we describe the composition and
organization of protein domains within the proteomes of fly, worm, and yeast and examine the
representation in each genome of a subset of genes that have been directly implicated as
causative agents of human disease. Then we compare some fundamental cellular and
developmental processes: the cell cycle, cell structure, cell adhesion, cell signaling, apoptosis,
neuronal signaling, and the immune system. In each case, we present a summary of what we
have learned from the sequence of the fly genome and how the components that carry out these
processes differ in other organisms. We end by presenting some observations on what we have
learned, the obvious questions that remain, and how knowledge of the sequence of the
Drosophila genome will help us approach new areas of inquiry.
The “Core Proteome”
How many distinct protein families are encoded in the genomes of D. melanogaster, C.
elegans, and S. cerevisiae (1), and how do these genomes compare with that of a simple
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prokaryote, Haemophilus influenzae? We carried out an “all-against-all” comparison of protein
sequences encoded by each genome using algorithms that aim to differentiate paralogs—highly
similar proteins that occur in the same genome—from proteins that are uniquely represented
(Table 1). Counting each set of paralogs as a unit reveals the “core proteome”: the number of
distinct protein families in each organism. This operational definition does not include
posttranslationally modifed forms of a protein or isoforms arising from alternate splicing.
In Haemophilus, there are 1709 protein coding sequences, 1247 of which have no sequence
relatives within Haemophilus (2). There are 178 families that have two or more paralogs,
yielding a core proteome of 1425. In yeast, there are 6241 predicted proteins and a core
proteome of 4383 proteins. The fly and worm have 13,601 and 18,424 (3) predicted protein-
coding genes, and their core proteomes consist of 8065 and 9453 proteins, respectively. It is
remarkable that Drosophila, a complex metazoan, has a core proteome only twice the size of
that of yeast. Furthermore, despite the large differences between fly and worm in terms of
development and morphology, they use a core proteome of similar size.
Gene Duplications
Much of the genomes of flies and worms consists of duplicated genes; we next asked how these
paralogs are arranged. The frequency of local gene duplications and the number of their
constituent genes differ widely between fly and worm, although in both genomes most paralogs
are dispersed. The fly genome contains half the number of local gene duplications relative to
C. elegans (4), and these gene clusters are distributed randomly along the chromosome arms;
in C. elegans there is a concentration of gene duplications in the recombinogenic segments of
the autosomal arms (1). In both organisms, approximately 70% of duplicated gene pairs are on
the same strand (306 out of 417 for D. melanogaster and 581 out of 826 for C. elegans). The
largest cluster in the fly contains 17 genes that code for proteins of unknown function; the next
largest clusters both consist of glutathione S-transferase genes, each with 10 members. In
contrast, 11 of 33 of the largest clusters in C. elegans consist of genes coding for seven
transmembrane domain receptors, most of which are thought to be involved in chemosensation.
Other than these local tandem duplications, genes with similar functional assignment in the
Gene Ontology (GO) classification (5) do not appear to be clustered in the genome.
We next compared the large duplicated gene families in fly, worm, and yeast without regard
to genomic location. All of the known and predicted protein sequences of these three genomes
were pooled, and each protein was compared to all others in the pool by means of the program
BLASTP. Among the larger protein families that are found in worms and flies but not yeast
are several that are associated with multicellular development, including homeobox proteins,
cell adhesion molecules, and guanylate cyclases, as well as trypsinlike peptidases and esterases.
Among the large families that are present only in flies are proteins involved in the immune
response, such as lectins and peptidoglycan recognition proteins, transmembrane proteins of
unknown function, and proteins that are probably fly-specific: cuticle proteins, peritrophic
membrane proteins, and larval serum proteins.
Gene Similarities
What fraction of the proteins encoded by these three eukaryotes is shared? Comparative
analysis of the predicted proteins encoded by these genomes suggests that nearly 30% of the
fly genes have putative orthologs in the worm genome. We required that a protein show
significant similarity over at least 80% of its length to a sequence in another species to be
considered its ortholog (6). We know that this results in an underestimate, because the length
requirement excludes known orthologs, such as homeodomain proteins, which have little
similarity outside the homeodomain. The number of such fly-worm pairs does not decrease
much as the similarity scores become more stringent (Table 2A), which strongly suggests that
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we have indeed identified orthologs, which may share molecular function. Nearly 20% of the
fly proteins have a putative ortholog in both worm and yeast; these shared proteins probably
perform functions common to all eukaryotic cells.
We also compared the proteins of fly, worm, and yeast to mammalian sequences. Most
mammalian sequences are available as short expressed sequence tags (ESTs), so we dispensed
with the requirement for similarity over 80% of the length of the proteins. Table 2B presents
these data. Half of the fly protein sequences show similarity to mammalian proteins at a cutoff
of E < 10−10 (where E is expectation value), as compared to only 36% of worm proteins. This
difference increases as the criteria become more stringent: 25% versus 15% at E < 10−50 and
12% versus 7% at E < 10−100. Because many of the comparisons are with short sequences, it
is likely that many of these sequence similarities reflect conserved domains within proteins
rather than orthology. However, it does suggest that the Drosophila proteome is more similar
to mammalian proteomes than are those of worm or yeast.
Protein Domains and Families
Proteins are often mosaic, containing two or more different identifiable domains, and domains
can occur in different combinations in different proteins. Thus, only a portion of a protein may
be conserved among organisms. We therefore performed a comparative analysis of the protein
domains composing the predicted proteomes from D. melanogaster, C. elegans, and S.
cerevisiae using sequence similarity searches against the SWISS-PROT/TrEMBL
nonredundant protein database (7), the BLOCKS database (8), and the InterPro database (9).
The 200 most common fly protein families and domains are listed in Table 3, and the 10 most
highly represented families in worm and yeast are shown in Table 4. InterPro analyses plus
manual data inspection enabled us to assign 7419 fly proteins, 8356 worm proteins, and 3056
yeast proteins to either protein families or domain families. We found 1400 different protein
families or domains in all: 1177 in the fly, 1133 in the worm, and 984 in yeast; 744 families
or domains were common to all three organisms.
Many protein families exhibit great disparities in abundance, and only the C2H2-type zinc
finger proteins and the eukaryotic protein kinases are among the top 10 protein families
common to all three organisms. There are 352 zinc finger proteins of the C2H2 type in the fly
but only 138 in the worm; whether this reflects greater regulatory complexity in the fly is not
known. The protein kinases constitute approximately 2% of each proteome. Curation of the
genomic data revealed that Drosophila has approximately 300 protein kinases and 85 protein
phosphatases, around half of which had previously been identified. In contrast, there are
approximately 500 kinases and 185 phosphatases in the worm; the difference is largely due to
the worm-specific expansion of certain families such as the CK1, FER, and KIN-15 families.
There are currently approximately 600 kinases and 130 phosphatases in humans, and it is
expected that these figures will rise to 1100 and 300, respectively, when the sequence of the
human genome is completed (10). Of the proteins uncovered in this analysis, over 70% exhibit
sequence similarity outside the kinase or phosphatase domain to proteins in other species. In
the kinase group, approximately 75% are serine/threonine kinases, and 25% are tyrosine or
dual-specificity kinases. Over 90% of the newly discovered kinases are predicted to
phosphorylate serine/threonine residues; this group includes the first atypical protein kinase C
isoforms identified in Drosophila. In addition, we found counterparts of the mammalian
kinases CSK, MLK2, ATM, and Peutz-Jeghers syndrome kinase, and additional members of
the Drosophila GSK3B, casein kinase I, SNF1-like, and Pak/STE20-like kinase families. In
the fly protein phosphatase group, approximately 42% are predicted to be serine/threonine
phosphatases; 48% are tyrosine or dual-specificity phosphatases. Among the newly discovered
phosphatases, 35% are serine/threonine phosphatases, most of which are related to the protein
phosphatase 2C family, and 65% are tyrosine or dual-specificity phosphatases. The fly and
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worm both contain close relatives to many of the known mammalian lipid kinases and
phosphatases; however, no SH2-containing inositol 5′ phosphatase SHIP is apparent. Finally,
it has been found that the assembly of kinase signaling complexes in vertebrate cells is aided
by the presence of scaffolding and adaptor molecules, many of which contain phosphoprotein
binding domains; we found 85 such proteins in the fly, including counterparts to IRS, VAV,
SHC, JIP, and MP1.
Two remarkable findings emerge from the peptidase data that may reflect different approaches
to growth and development in flies, worms, and humans. The pattern and distribution of
peptidase types are similar between the fly and the worm: there are approximately 450
peptidases in the fly and 260 in the worm. The difference is due almost entirely to the expansion
or contraction of a single class of trypsin-like (S1) peptidases. C. elegans has seven of this
class and yeast has one, but the fly has 199. Of these, 163 are small proteins of approximately
250 amino acids containing single trypsin domains; very few are mosaic proteins. The
remainder have either multiple trypsin-like domains or long stretches of amino acids with no
readily identifiable motif, usually at the NH2-terminus. In humans, trypsin-like peptidases
perform diverse functions in digestion, in the complement cascade, and in several other
signaling pathways (11), and flies may have a similarly wide range of uses for these proteins.
The extensively characterized members of this family, which include Snake, Easter, Nudel,
and Gastrulation-defective, are all key members of a regulatory cascade that controls
dorsoventral patterning in the fly (12). In addition, flies have only two members of the M10
class of peptidases, which include the matrix metalloproteases, collagenases, and gelatinases
that are essential for tissue remodeling and repair in vertebrates.
The number of identifiable multidomain proteins is similar in the fly and the worm: 2130 and
2261, respectively. Yeast has only 672 (Table 5). Part of this difference is accounted for by
proteins with extracellular domains involved in cell-cell and cell-substrate contacts (13), such
as the immunoglobulin domain–containing proteins, which are more abundant in flies than in
worms (153 versus 70) and are nonexistent in yeast. Two other common extracellular domains
occur in similar numbers in fly and worm: EGF (110 versus 109, respectively) and fibronectin
type III (46 versus 43) but are rare or absent in yeast. Extracellular regions of proteins often
contain a variety of repeated domains (14), and so these proteins may account for our finding
that flies have a larger number of proteins with multiple InterPro domains than either worms
or yeast (2107 versus 1747 and 525, respectively) (Table 6). Some multidomain proteins of
the fly are particularly heterogeneous: Two low-density lipoprotein receptor–related proteins
have 75 InterPro domains each. Another protein of unknown function has 62 InterPro domains;
the most heterogeneous worm and yeast proteins [SWISS-PROT/TrEMBL accession numbers
(AC), Q04833 and P32768, respectively] have 61 and 18 InterPro domains, respectively. There
can be extensive repetition of the same domain within a protein; for example, an
immunoglobulin-like domain is repeated 52 times within one protein of unknown function in
the fly. The large worm protein UNC-89 contains 48 immunoglobulin-like domains (SWISS-
PROT/TrEMBL AC, Q17362). In contrast, the largest number of repeats in yeast, of a C2H2-
type zinc finger domain, occurs nine times in the transcription factor TFIIIA (SWISS-PROT/
TrEMBL AC, P39933).
The heterotrimeric GTP-binding protein (G protein)–coupled receptors (GPCRs) are a large
protein family in flies, worms, and vertebrates whose members are involved in synaptic
function, hormonal physiology, and the regulation of morphological movements during
gastrulation and germ band extension (15). There are predicted to be at least 700 GPCRs in
the human genome (16) and roughly 1100 GPCRs in C. elegans (17). We found approximately
160 GPCR genes in the Drosophila genome, 57 of which appear to be olfactory receptors.
Drosophila, C. elegans, and vertebrates each have diverse families of odorant receptors that,
although recognizable as GPCRs, are unrelated by sequence and therefore apparently evolved
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independently. The number of odorant receptors in vertebrates ranges from around 100 in
zebrafish and catfish to approximately 1000 in the mouse; C. elegans also has approximately
1000. In the fly, as in zebrafish and mouse, there is a correlation between the number of odorant
receptors and the number of discrete synaptic structures called glomeruli in the olfactory
processing centers of the brain (16,18). In the mouse, each glomerulus is dedicated to receiving
axonal input from neurons expressing a particular odorant receptor (16). Therefore, the
correlation between number of odorant receptors and number of glomeruli may reflect a
conservation in the organizational logic of odor recognition in insect and vertebrate brains.
Although the fly odorant receptors are extremely diverse, there are a number of subfamilies
whose members share 50 to 65% sequence identity. The distribution of odorant receptor genes
is different among these organisms as well. Unlike C. elegans or vertebrate odorant receptors,
which are in large linked arrays, the fly odorant receptor genes are distributed as single genes
or in arrays of two or three. Vertebrate receptors are encoded by intronless genes, but both fly
and worm receptor genes have multiple introns. These distinctions suggest that in addition to
differences in the sequences of the odorant receptors of the different organisms, the processes
generating the families of receptors may have differed among the lineages that gave rise to
flies, worms, and vertebrates.
The data suggest conservation of hormone receptors between flies and vertebrates;
nevertheless, there is a greater diversity of hormone receptors in both C. elegans and vertebrates
than in Drosophila. Insects are subject to complex hormonal regulation, but no apparent
homologs of vertebrate neuropeptide and hormone precursors were identified. However, many
receptors with sequence similarity to vertebrate receptors for neurokinin, growth hormone
secretagogue, leutotropin (follicle-stimulating hormone and luteinizing hormone), thyroid-
stimulating hormone, galanin/allatostatin, somatostatin, and vasopressin were identified. Other
GPCRs include a seventh Drosophila rhodopsin and homologs of adenosine, metabotropic
glutamate, γ-aminobutyric acid (GABA), octopamine, serotonin, dopamine, and muscarinic
acetylcholine receptors. In addition, there are GPCRs that are unique to Drosophila, others
with sequence similarity to C. elegans and human orphan receptors, and an insect diuretic
hormone receptor that is closely related to vertebrate corticotropin-releasing factor receptor.
Finally, we found several atypical seven-transmembrane domain receptors, including 10
Methuselah (MTH)–like proteins and four Frizzled (FZ)–like proteins. A mutation in mth
increases the fly's life-span and its resistance to various stresses (19); the FZ-like proteins
probably serve as receptors for different members of the Wingless/Wnt family of ligands.
Human Disease Genes
Studies in model organisms have provided important insights into our understanding of genes
and pathways that are involved in a variety of human diseases. In order to estimate the extent
to which different types of human disease genes are found in flies, worms, and yeast, we
compiled a set of 289 genes that are mutated, altered, amplified, or deleted in a diverse set of
human diseases and searched for similar genes in D. melanogaster, C. elegans, and S.
cerevisiae, as described in the legend to Fig. 1. Of these 289 human genes, 177 (61%) appear
to have an ortholog in Drosophila (Fig. 1). Only proteins with similar domain structures were
considered to be orthologs; this judgment was made by human inspection of the InterPro
domain composition of the fly and human proteins. The importance of human inspection, as
well as consideration of published information, is underscored by the fact that some sequences
with extremely high similarity scores to proteins encoded by fly genes, such as LCK and
Myotonic Dystrophy 1, were judged not to be orthologous, but others with relatively low scores,
such as p53 and Rb1, were considered to be orthologs. We attempted this additional level of
analysis only for the fly proteins, as the lower overall level of similarity of worm and yeast
proteins made these subjective judgments even more difficult. Some of the human disease
genes that are absent in Drosophila reflect clear differences in physiology between the two
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organisms. For instance, none of the hemoglobins, which are mutated in thalassemias, have
orthologs in Drosophila. In flies, oxygen is delivered directly to tissues via the tracheal system
rather than by circulating erythrocytes. Similarly, several genes required for normal
rearrangement of the immunoglobulin genes do not have Drosophila orthologs.
Of the cancer genes surveyed, 68% appear to have Drosophila orthologs. In addition to
previously described proteins, these searches identified clear protein orthologs for menin
(MEN; multiple endocrine neoplasia type 1), Peutz-Jeghers disease (STK11), ataxia
telangiectasia (ATM), multiple exostosis type 2 (EXT2), a second bCL2 family member, a
second retinoblastoma family member, and a p53-like protein. Despite its relatively low
sequence similarity to the human genes, the Drosophila gene encoding p53 was considered an
ortholog because it shows a conserved organization of functional domains, and its DNA binding
domain includes many of the same amino acids that appear to be hot spots for mutations in
human cancer. Comparison of the fly p53-like protein with the human p53, p63, and p73
proteins suggests that it may represent a progenitor of this entire family. In mammalian cells,
levels of p53 protein are tightly regulated in vivo by its interaction with the Mdm2 protein,
which in turn binds to p19ARF (20). This mode of regulation, which modulates the activity of
p53 but probably not of p63 or p73 (21), may not apply to the Drosophila protein, because we
have not been able to identify orthologs of either Mdm2 or p19ARF in Drosophila.
Interestingly, likely orthologs of the breast cancer susceptibility genes BRCA1 and BRCA2
were not found in Drosophila. In most instances, cancer genes that have a Drosophila ortholog
also have an ortholog in C. elegans, although the extent of sequence similarity to the worm
gene is lower. In a minority of instances, a C. elegans ortholog was clearly absent. Cancer
genes with orthologs in Drosophila and apparently not in C. elegans include p53 and
neurofibromatosis type 1 (22), the two genes implicated in tuberous sclerosis (TSC1 and
TSC2) (23), and MEN. The two TSC gene products are thought to bind to each other and may
function in a pathway that is conserved between humans and Drosophila but is absent in C.
elegans and S. cerevisiae. However, the limitations of this type of analysis are clearly illustrated
by our inability to find a bCL2 ortholog in C. elegans using these search parameters. The C.
elegans ced-9 gene has been shown to function as a bCL2 homolog, and its protein is 23%
identical to the human protein over its entire length (24).
Numerous orthologs of neurological genes are also found in the Drosophila genome. Some,
such as Notch (CADASIL syndrome), the beta amyloid protein precursorlike gene, and
Presenilin (Alzheimer's disease), were already known from previous studies in the fly. The
genome sequencing effort has uncovered several additional genes that are likely to be orthologs
of human neurological genes, such as tau (frontotemporal dementia with Parkinsonism), the
Best macular dystrophy gene, neuroserpin (familial encephalopathy), genes for limb girdle
muscular dystrophy types 2A and 2B, the Friedreich ataxia gene, the gene for Miller-Dieker
lissencephaly, parkin (juvenile Parkinson's disease), and the Tay-Sachs and Stargardt's disease
genes. Several genes implicated in expanded polyglutamine repeat diseases, including
Huntington's and spinal cerebellar ataxia 2 (SCA2), are found in the fruit fly. Most human
neurological disease genes surveyed were also detected in C. elegans, and some were even
found in yeast, although a few examples are apparently present only in Drosophila, such as
the Parkin and SCA2 orthologs.
Among genes implicated in endocrine diseases, those functioning in the insulin pathway are
mostly conserved. In contrast, members of pathways involving growth hormone,
mineralocorticoids, thyroid hormone, and the proteins that regulate body mass in vertebrates,
such as those encoding leptin, do not appear to have Drosophila orthologs. Surprisingly, a
protein that shows significant sequence similarity to the luteinizing hormone receptor is present
in Drosophila (25). The physiological ligand for this receptor is not known. A number of genes
that have been implicated in human renal disorders have orthologs in Drosophila, despite the
Rubin et al. Page 7
Science. Author manuscript; available in PMC 2009 September 29.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
differences between human kidneys and insect Malpighian tubules. In many instances, these
gene products are involved in fluid and electrolyte transport across epithelia. Not surprisingly,
most disease genes that function in intracellular metabolic pathways appear to have
Drosophila orthologs.
Developmental and Cellular Processes
Developmental strategies in various phyla are overtly very different, from the fixed cell lineage
of C. elegans to the syncytial embryogenic development of the fly, to early embryogenesis in
amphibians and mammals. A number of major processes—cell division, cell shape, signaling
pathways, cell-cell and cell-substrate adhesion, and apoptosis— determine the developmental
outcomes of these very different embryos. Although there are many more, such as the processes
that determine embryonic gradients, cell polarities, and cell movement, here we examine the
first five, beginning with cell cycle components, and examine what new insights have been
gained from the genomic data that affect our knowledge of the evolution of developmental
processes. We then discuss the processes of neuronal signaling and innate immunity.
Cell cycle
Despite conservation of the mechanisms regulating cell cycle progression, many of the
functions governing this progression are encoded by gene families whose individual members
are not conserved between vertebrates and yeast. For example, the cyclins of S. cerevisiae can
be divided into a G1 class (Cln1, Cln2, and Cln3) and an S/G2 class (Clb1 through Clb6); it is
not possible to identify orthologs of individual vertebrate cyclins. Consequently, analysis of
the roles of particular vertebrate cell cycle genes benefits from a genetic model in which
parallels are more evident. Analysis of the Drosophila genome sequence supports and extends
previous suggestions of strong parallels between fly and human cell cycle regulators. Orthologs
of vertebrate cell cycle cyclins—cyclin A (CycA), CycB, CycB3, CycE, and CycD—have been
identified in Drosophila, as have orthologs of cyclins that appear to have roles in transcription:
CycC, CycH, CycK, and CycT. Apparent orthologs of these cyclins can be also be found in
C. elegans; however, the level of similarity to the vertebrate members is invariably substantially
less. Indeed, BLAST comparisons suggest that vertebrate and Drosophila CycA and CycB
share more sequence similarity with yeast than with proposed C. elegans orthologs.
Examination of other cell cycle regulators confirms that quite precise comparisons can be made
between vertebrates and flies; parallels with yeast are looser. For example, like vertebrates,
Drosophila uses several different cyclin-dependent kinases (Cdks) to regulate different aspects
of the cell cycle; S. cerevisiae and Schizosaccharomyces pombe use only one. Cloning efforts
and the genome sequence revealed Drosophila orthologs of vertebrate Cdk1 (cdc2) and Cdk2
(cdc2c), as well as a single Drosophila Cdk (Cdk4/6) with close similarity to both Cdk4 and
Cdk6. As in vertebrates, Drosophila has two distinct kinases that add inhibitory phosphate to
Cdk1, the previously identified Wee, and a recently recognized homolog of Myt1, which was
initially identified as a membrane-associated inhibitory kinase in Xenopus (26). C. elegans also
has two homologs of these kinases (Wee1.1 and Wee1.3); however, similarity scores do not
place these into distinct Wee1 and Myt1 subtypes. Each of these genes appears to be present
in a single copy, a factor that simplifies genetic interpretations.
The retinoblastoma gene product pRb is a crucial cell cycle regulator in mammals and is thought
to modulate S-phase entry via its interactions with the transcriptional regulator E2F and its
dimerization partner (DP). This important mode of regulation is not found in yeast, but many
components of the Rb pathway have been identified and studied in Drosophila (27). The
sequencing effort uncovered a second Rb-related gene in Drosophila and confirmed the
existence of only two E2F family members and a single DP ortholog. C. elegans also has an
Rb-related gene, isolated in a genetic screen for mutations affecting cell fate decisions (28),
but it has not been shown to play a direct role in cell cycle regulation. Also evident from the
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sequence are eight skp-like genes and six cullin-related genes. The Skp and Cullin proteins
function in a complex that mediates the degradation of specific target proteins during crucial
cell cycle transitions. Further exploration of the genome sequence should define orthologs to
most vertebrate cell cycle genes and lead to genetic tests of their regulation and function.
Cytoskeleton
A large number of proteins link events at the cell surface with cytoskeletal networks and
intracellular messengers (13). We found approximately 230 genes (approximately 2% of the
predicted genes) that encode cytoskeletal structural or motor proteins; these represent most
major families found in other invertebrates and vertebrates (29). The fraction of the
Drosophila genome devoted to cytoskeletal functions appears to be somewhat smaller than
that found in C. elegans (5%) (30); whether this reflects a true biological difference or a
difference in classification criteria remains to be discovered. Of the Drosophila cytoskeletal
genes, 90 encode proteins belonging to the kinesin, dynein, or myosin motor superfamilies, or
accessory or regulatory proteins known to interact with the motor protein subunits.
Approximately 80 genes encode actin-binding proteins, including proteins belonging to the
spectrin/α-actinin/dystrophin superfamily of membrane cytoskeletal and actin–cross-linking
proteins. Twenty genes encode proteins that are likely to bind microtubules, based on their
similarity to microtubule-binding proteins found in other organisms. Fourteen genes encode
members of the actin superfamily, 12 encode members of the tubulin superfamily, and 5 encode
septins. Overall, the representation of predicted cytoskeletal protein types and families is
similar to what has been found for C. elegans, although Drosophila has many more dyneins,
probably because C. elegans lacks motile cilia and flagella.
Among this collection of cytoskeletal genes are several interesting and in some cases long-
sought genes. One gene encodes a protein with striking homology to proteins of the tau/MAP2/
MAP4 family that share a characteristic repeated microtubule-binding domain. Two encode
new tubulins; one appears most closely related to α-tubulin, and the other appears most closely
related to β-tubulin, both with approximately 50% identity. Neither new tubulin has greater
similarity to the other, more divergent members of the tubulin superfamily, such as γ-, δ-, or
ε-tubulin (31). Thus, both Drosophila and C. elegans appear to lack δ- and ε-tubulin, even
though δ-tubulin is highly conserved between Chlamydomonas and humans. There are also
three new members of the central motor domain family of kinesins that encode nonmotor
proteins that regulate microtubule dynamics (32). There are clear homologs of the dystrophin
complex and of dystrobrevin. Finally, the fly lacks cytoplasmic intermediate filament proteins,
other than nuclear lamins, although other invertebrates, including C. elegans, appear to have
genes encoding these (33). Drosophila and C. elegans both also appear to lack a gene encoding
kinectin, the proposed receptor for kinesin and cytoplasmic dynein on vesicles and organelles
(34). Flies and worms must thus use different proteins to link microtubule motors to vesicles
and organelles.
Cell adhesion
Cell-cell adhesion and cell-substrate adhesion molecules have been crucial to the development
of multicellular organisms and the evolution of complex forms of embryogenesis (13). The
transmembrane extracellular matrix-cytoskeleton linkage via integrins is ancient. There are
five α and two β integrins in the fly, two α and one β in C. elegans, and at least 18 α and eight
β in vertebrates. Integrin-associated cytoplasmic proteins (talin, vinculin, α-actinin, paxillin,
FAK, p130CAS, and ILK) are encoded by single-copy fly genes, as are tensin and syndecan.
Two genes for type IV collagen subunits and genes for the three subunits of laminin were
already known in the fly. Analysis of the genome revealed no more laminin genes and only
one more collagen, which is closest to types XV and XVIII of vertebrates. A counterpart of
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this collagen is found in C. elegans, which has on the order of 170 collagens. Most important,
it appears that the core components of basement membranes (two type IV collagen subunits,
three laminin subunits, entactin/nidogen, and one perlecan), are all present in flies. This
constitution of basement membranes was clearly established early in evolution and has been
well conserved in metazoans; remarkably, the fly preserves the linked head-to-head
organization of vertebrate type-IV collagen genes. In contrast to this conservation, many well-
known vertebrate integrin (ECM) ligands are absent from the fly: fibronectin, vitronectin,
elastin, von Willebrand factor, osteopontin, and fibrillar collagens are all missing.
The fly has three classic cadherins, two of which are closely linked, but no protocadherins of
the type found in vertebrates as clusters with common cytoplasmic domains (35). Vertebrates
have three such clusters encoding over 50 protocadherins and close to 20 classical cadherins.
The fly has no reelin, an ECM ligand for CNR-type protocadherins in vertebrates (36).
However, there are other fly proteins with cadherin repeats, including the previously known
Fat, Dachsous, and Starry night, and a new very large protein related to Fat. C. elegans has 15
genes containing cadherin repeats; the number in humans is now 70 and will undoubtedly rise
(13).
Cell signaling
Components of known signaling pathways in the fly and worm have largely been uncovered
by examinations of developmental systems. It is a tribute to the previous genetic analyses done
in these organisms that only a modest number of new components of the known signaling
pathways were revealed by analysis of the genomic sequence. The core components defined
in flies and worms have been used in modified and expanded forms in vertebrates (37). The
predominant pathways—transforming growth factor–β (TGF-β), receptor tyrosine kinases,
Wingless/Wnt, Notch/lin-12, Toll/IL1, JAK/STAT/cytokine, and Hedgehog (HH) signaling
networks—all have largely conserved fly and vertebrate components. The worm, by contrast,
does not appear to possess the HH or Toll/IL1 pathways, nor does it have all of the components
of the Notch/lin-12 network (38). Two new proteins of the TGF-β superfamily were identified,
bringing the total to seven; all seven are members of the bone morphogenetic protein (BMP)
or β-activin subfamilies. We detected no representatives of the other branches of this
superfamily, namely the TGF-β, α-inhibin, and Mullerian inhibiting substance (MIS)
subfamilies. Three new members of the Wingless/Wnt family were identified, bringing the
total to seven. Each of these proteins has sequence similarity to a different vertebrate Wnt
protein; this ancient family clearly underwent much of its expansion before the divergence of
the arthropod and chordate lineages. There is only one member of the Notch and HH families,
in contrast to the many members of these families in vertebrates.
Apoptosis
The core apoptotic machinery of Drosophila shares many features in common with that of
mammals. Many apoptosis-inducing signals lead to activation of members of the caspase
family of proteases. These proteases function in apoptotic processes as cell death signal
transducers and death effectors, and in nonapoptotic processes in flies and mammals (39).
Drosophila contains genes encoding 8 caspases, as compared to 4 in the worm and at least 14
in mammals. Three of the fly caspases contain long NH2-terminal prodomains of 100 to 200
amino acids that are characteristic of caspases that function as signal transducers. These
prodomains are thought to mediate caspase recruitment into signaling complexes in which
activation occurs in response to oligomerization. In one pathway described in mammals but
not in worms, death signals cause the release of proteins, including cytochrome c and the
apoptosis-inducing factor (AIF), from mitochondria (40). The human protein Apaf-1, in
conjunction with cytochrome c, activates CARD domain–containing caspases (41).
Drosophila has an Apaf-1 counterpart, a CARD domain–containing caspase, and AIF;
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Drosophila also has counterparts to the caspase-activated DNAse CAD/CPAN/DFF40, its
inhibitor ICAD/DFF45, and the chromatin condensation factor Acinus (42).
Pro- and anti-apoptotic BCL2 family members regulate apoptosis at multiple points (43).
Drosophila encodes two BCL2 family proteins, though more divergent family members may
exist. Fifteen BCL2 family proteins have been identified in mammals and two in the worm. In
addition, inhibitor of apoptosis (IAP) family proteins negatively regulate apoptosis (44). They
are defined by the presence of one or more NH2-terminal repeats of a BIR domain, a motif that
is essential for death inhibition. Drosophila has four proteins with this motif, as compared to
seven identified thus far in mammals. There are several BIR domain–containing proteins in
C. elegans and yeast, but none has been implicated in cell death regulation. Reaper (RPR),
Wrinkled (W), and Grim are essential Drosophila cell death activators (45). Orthologs have
not been identified in other organisms, but they are likely to exist because RPR, W, and Grim
induce apoptosis in vertebrate systems and physically interact with apoptosis regulators that
include IAPs and the Xenopus protein Scythe (46), for which there is a predicted Drosophila
homolog.
Neuronal signaling
The neuronal signaling systems in flies, worms, and vertebrates reveal extensive conservation
of some components, as well as extreme divergence, or the total absence, of others. There is
no voltage-activated sodium channel in the worm (17); flies and vertebrates generate sodium-
dependent action potentials. The fly genome encodes two pore-forming subunits for sodium
channels (Para and NaCP60E), and also four voltage-dependent calcium channel α subunits,
including one T-type/α1G, one L-type/α1D (Dmca1D), one N-type/α1A (Dmcα1A), and one
protein that is more similar to an outlying C. elegans protein than to known vertebrate calcium
channels. Additional fly calcium channel subunits include one (β, one γ 2, and three α 2
subunits.
The worm genome encodes over 80 potassium channel proteins (17); the fly genome has only
30. The extent to which these different family sizes contribute to the establishment of unique
electrical signatures is unknown. The fly potassium channel family includes five Shaker-like
genes (Shaker, Shab, Shal, and two Shaws); a large conductance calcium-activated channel
gene (slowpoke); a slack subunit relative; three members of the eag family (eag, sei, and elk);
one small conductance calcium-regulated channel gene; one KCNQ channel gene; and four
cyclic nucleotide–gated channel genes. In addition, there are 50 TWIK members in the worm,
but only 11 fly members of the two-pore/TWIK family with four transmembrane domains.
There are also three fly members of the inward rectifier/two transmembrane family. Finally,
neither the fly nor the worm has discernible relatives of a number of mammalian channel-
associated subunits such as minK and miRP1.
There are also major differences postsynaptically. C. elegans has approximately 100 members
of a family of ligand-gated ion channels (17); flies have about 50. The worm has 42 nicotinic
acetylcholine receptor subunits and 37 GABA(A)-like receptor subunits; the fly contains only
11 nicotinic receptor subunit genes and 12 GABA(A)/glycine-like receptor subunit genes. In
contrast, there are 30 members of the excitatory glutamate receptor family in the fly but only
10 in the worm. These include subtypes of the AMPA, kainate, NMDA, and delta families. In
addition, the fly genome contains a large number of PDZ-containing genes, approximately a
dozen of which encode proteins that have high sequence similarity to mammalian proteins that
interact with specific subsets of ion channels. We also found a number of additional ion channel
families, including three voltage-dependent chloride channels, 14 Trp-like channels, 24
amiloride-sensitive/degenerin-like sodium channels, one ryanodine receptor, one IP3 (inositol
1,4,5-trisphosphate) receptor, eight innexins, and two porins. C. elegans is missing a nitric
oxide synthase gene, copies of which occur in fly and vertebrate genomes.
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A large array of proteins mediates specific aspects of synaptic vesicle trafficking and
contributes to the conversion of electrical signals to neurotransmitter release. These
components of exocytosis and endocytosis are relatively well conserved with respect to both
domain structures and amino acid identities (50 to 90%). The fly has enzymes for the synthesis
of the neurotransmitters glutamate, dopamine, serotonin, histamine, GABA, acetylcholine, and
octopamine, and a family of conserved transporters is likely to be involved in loading vesicles
with these neurotransmitters. The conserved vesicular trafficking proteins, with 50 to 80%
amino acid identity, include members of the Munc-18, SCAMP, synaptogyrin, HRS2,
tomosyn, cysteine string protein, exocyst (SEC 5, 6, 7, 8, 10, 13, 15, EXO 70, and EXO84),
synapsin, rab-philin-3A, RIM, rab-3, CAPS, Mint, Munc-13, NSF, α and γ SNAP, DOC-2B,
latrophilin, Veli, CASK, VAP-33, Snapin, SV2, and complexin families. Generally, there is
only one homolog in Drosophila for every three to four isoforms in mammals. However, there
are eight fly synaptotagmin-like genes, making this the largest family of vesicle proteins in
Drosophila (47). However, there is no homolog of synaptophysin, an early candidate for a
vesicle fusion pore, which indicates a nonessential role in exocytosis for this particular protein
across phyla.
Membrane trafficking also requires interactions between compartment-specific vesicular and
target membrane proteins (v-SNAREs and t-SNAREs, respectively), whose subcellular
distribution and combinatorial binding patterns are predicted to define organelle identity and
targeting specificity (48). The completed fly genome allows us to address whether there is any
correlation between the increased developmental complexity of multicellular organisms and a
larger number of SNAREs than that found in unicellular organisms. In the fly, we find six
synaptobrevins, three SNAP-25s, 10 syntaxins, and four additional t-SNAREs (membrin,
BET1, UFE1, and GOS28), and the number of SNAREs is similar between yeast (49) and
Drosophila. Thus, basic subcellular compartmentalization and membrane trafficking to and
between these various compartments has not changed dramatically in multicellular versus
unicellular organisms. Dynamin, clathrin, the clathrin adapter proteins, amphiphysin,
synaptojanin, and a number of additional genes that encode proteins with defined endocytotic
motifs are all present.
In contrast to the conservation of the synaptic vesicle trafficking machinery, the few identified
proteins present at mammalian active zones, namely aczonin, bassoon, and piccolo, do not
have relatives in Drosophila. There are, however, numerous proteins in the fly with
combinations of C2 domains, PDZ domains, zinc fingers, and proline-rich domains, indicating
that the precise protein composition of active zones is likely to vary among metazoans. In
addition, Drosophila contains a neurexin III gene and four neuroligin genes that may be part
of a neurexin-neuroligin complex that has been widely proposed to provide a synaptic scaffold
for linking pre- and postsynaptic structures in mammals (50). Potential agrin and Musk genes
are also present, though the overall sequence similarity is low.
Immunity
Multicellular organisms have elaborate systems to defend against microbial pathogens. Only
vertebrates have an acquired immune system, but both vertebrates and invertebrates share a
more primitive innate immune system. Innate immunity is based on the detection of common
microbial molecules such as lipopolysaccharides and peptidoglycans by a class of receptors
known as pattern recognition receptors (51). We identified a large family of genes encoding
homologs of receptors that are involved in microbial recognition in other organisms. These
include two new homologs of the Drosophila Scavenger Receptors (dSR-CI), nine members
of the CD36 family, 11 members of the peptidoglycan recognition protein (PGRP) family,
three Gram-negative binding protein (GNBP) homologs, and several lectins (52).
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The recognition of infection by immuno-responsive tissues induces a battery of defense genes
via Toll/nuclear factor kappa B (NF-κB) pathways in both Drosophila and mammals (53). The
Toll receptor was initially discovered as an essential component of the pathway that establishes
the dorsoventral axis of the Drosophila embryo. Recent genetic studies now reveal that Toll
signaling pathways are key mediators of immune responses to fungi and bacteria in both
Drosophila and mice (53). We found seven additional homologs of Toll proteins in
Drosophila, all of which are more similar to each other than to their mammalian counterparts.
Some of these other Toll proteins, like 18-wheeler, will probably mediate innate immune
responses. In Drosophila, infection by at least some microbes induces a proteolytic cascade
that leads to the processing of Spaetzle (SPZ), a cytokine-like protein, which then activates
Toll (53). We found two proteins related to SPZ with similarities that include most or all of
the cysteine residues of SPZ. Given the presence of multiple Toll-like receptors in
Drosophila, these new SPZ-like proteins may also function in the immune system. With the
exception of the two I-κB kinase homologs and the three rel proteins (Dorsal, Dif, and Relish),
the Drosophila genome appears to contain only single copies of the genes encoding
intracellular components of the Toll pathway: Tube, Pelle, and Cactus. How do the different
Toll receptors trigger specific immune responses using the same intracellular intermediates?
One explanation is that additional signaling components remain unidentified; another
explanation is crosstalk with other signaling pathways. In contrast, a Toll ortholog has not been
identified in C. elegans, although there are some Toll-like receptors. C. elegans, in addition,
does not possess homologs of NF-κB/dorsal transcriptional activators that function
downstream of Toll. Although it is probable that the worm has retained parts of the innate
immunity network, there is no clear evidence of an inducible host defense system in the worm.
One of the most potent innate immune responses in insects is the transcriptional induction of
genes encoding antimicrobial peptides (53). In contrast to Metchnikowin, Drosocin, and
Defensin peptides, which are encoded by single genes, the sequence data indicate that, like the
previously identifed cecropin clusters, several antimicrobial peptides are encoded by gene
families that are larger than previously suspected. Four genes appear to encode antifungal
peptide Drosomycin isoforms, and two genes each code for the antibacterial proteins Attacin
and Diptericin. These additional genes may generate peptides with slightly different spectra of
antimicrobial activity or may simply amplify the antimicrobial response.
Concluding Remarks
What have we learned about the proteins encoded by the three sequenced eukaryotic genomes?
Some information emerges readily from the comparison of the fly, worm, and yeast genomes.
First, the core proteome sizes of flies and worms are similar and are only twice the size of that
of yeast. This is perhaps counterintuitive, because the fly, a multicellular animal with
specialized cell types, complex development, and a sophisticated nervous system, looks more
than twice as complicated as single-celled yeast. The lesson is that the complexity apparent in
the metazoans is not achieved by sheer number of genes (54). Second, there has been a
proliferation of bigger and more complex proteins in the two metazoans relative to yeast,
including, not surprisingly, more proteins with extracellular domains involved in cell-cell and
cell-substrate interactions. Finally, the population of multidomain proteins is somewhat larger
and more diverse in the fly than in the worm. There is presently no practical way to quantify
differences in biological complexity between two organisms, however, so it is not possible to
correlate this increased domain expansion and diversity in the fly with differences in
development and morphology.
The availability of the annotated sequence of the Drosophila genome enhances the fly's
usefulness as an experimental organism. By greatly facilitating positional cloning, the genome
sequence will increase the efficiency of genetic screens that seek to identify genes underlying
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many complex processes of cell biology, development, and behavior. Such screens have been
the mainstay of Drosophila research and have contributed enormously to our knowledge of
metazoan biology. The genome sequencing effort has revealed a number of previously
unknown counterparts to human genes involved in cancer and neurological disorders; for
example, p53, menin, tau, limb girdle muscular dystrophy type 2B, Friedrich ataxia, and
parkin. All of these fly genes are present in a single copy in the genome and can be genetically
analyzed without uncertainty about redundant copies. More genetic screens are important in
order to uncover interacting network members. Orthologs of these network members can then
be sought in the human genome to determine if alterations in any of them predispose humans
to the disease in question, an experimental paradigm that has already been successfully
executed in several cases. Flies can also play an important role in exploring ways to rectify
disease phenotypes. For example, at least 10 human neurodegenerative diseases are caused by
expansion of polyglutamine repeats (55). Human proteins containing expanded polyglutamine
repeats have been expressed in flies, resulting in the formation of nuclear inclusions that contain
the protein as well as other shared components (56), just as in humans. It has been shown that
directed expression of the human HSP70 chaperone in the fly can totally suppress
neurodegeneration resulting from expression of the human spinocerebellar ataxia type 3 protein
(57). The power and speed of this in vivo system are unparalleled, and we anticipate the
increased use of such “humanized” fly models.
Knowing the complete genomic sequence also allows new experimental approaches to long-
standing problems. For example, it makes it possible to study networks of genes rather than
individual genes or pathways. Assaying the level of transcription of every gene in the genome
makes it at least theoretically possible to monitor the expression of an entire network of genes
simultaneously. One problem that is approachable this way is the combinatorial control of gene
transcription. The fly genome appears to encode only about 700 transcription factors, and
mutations in over 170 have already been isolated and characterized. The techniques are
available to measure the changes in expression of every gene in individual cell types as a
consequence of loss or overexpression of each transcription factor. We can look for common
sequence elements in the promoters of coregulated genes and perform chromatin immuno-
precipitation to identify the in vivo binding sites of individual factors. For the first time, we
can envision obtaining the data needed to understand the behavior of a complex regulatory
network. Of course, collecting these data is a massive task, and developing methods to analyze
the data is even more daunting. But it is no longer ludicrous to try.
How big is the core proteome of humans? Vertebrates have many gene families with three or
four members: the HOX clusters, calmodulins, Ezrins, Notch receptors, nitric oxide synthases,
syndecans, and NF1 transcription factor genes are some examples (58). This is evidence for
two genome doublings during mammalian evolution, superimposed on which were the
amplifications and contractions over evolutionary time that uniquely characterize each lineage
(59). The human genome, with 80,000 or so genes, is likely to be an amplified version of a
very much smaller genome, and its core proteome may not be much larger than that of the fly
or worm; that is, the more complex attributes of a human being are achieved using largely the
same molecular components. The evolution of additional complex attributes is essentially an
organizational one; a matter of novel interactions that derive from the temporal and spatial
segregation of fairly similar components.
Finally, approximately 30% of the predicted proteins in every organism bear no similarity to
proteins in its own proteome or in the proteomes of other organisms. In other words, sequence
similarity comparisons consistently fail to give us information about nearly a third of the
components that make every organism uniquely itself. What does this mean with respect to the
evolution and function of these proteins? Does each genome contain a sub-population of very
rapidly evolving genes? One-third of randomly chosen cDNA clones do not cross-hybridize
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between D. melanogaster and Drosophila virilis (60). Even though these are distantly related
species, they are developmentally and morphologically very similar. Crystallographic data will
be needed to determine whether these proteins that have diverged in primary sequence have
maintained their three-dimensional structures or have diverged so far that new folds and
domains have formed.
Our first look at the annotated fly genome provokes these and other questions. Access to the
genomic sequence will help us design the experiments needed to answer them. The relative
simplicity and manipulability of the fly genome means that we can address some of these
biological questions much more readily than in vertebrates. That is, after all, what model
organisms are for.
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Fig. 1.
Fly (F), worm (W), and yeast (Y) genes showing similarity to human disease genes. This
collection of human disease genes was selected to represent a cross section of human
pathophysiology and is not comprehensive. The selection criteria require that the gene is
actually mutated, altered, amplified, or deleted in a human disease, as opposed to having a
function deduced from experiments on model organisms or in cell culture. Due to redundancy
in gene and protein sequence databases, a single reference sequence for each gene had to be
chosen. Most reference sequences represent the longest mRNA of several alternatives in
GenBank. Authoritative sources in the literature and electronic databases [Online Mendelian
Inheritance in Man (OMIM)] were also consulted. In all, 289 protein sequences met these
criteria. These were used as queries to search a database consisting of the sum total of gene
products (38,860) found in the complete genomes of fly, worm, and yeast. 12,953 was used as
the effective database size (the z parameter in BLAST). BLASTP searches were conducted as
described for full genome searches, except for the z parameter. To control for potential
frameshift errors in the Drosophila genome sequence, searches against a six-frame translation
of the entire genome (using TBLASTN) were also conducted with the disease gene sequences
using the z parameter above. Only two cases in which matches to genomic sequence were better
than to the predicted protein were found, and these were manually corrected to reflect the better
TBLASTN scores in the table. Results are scaled according to various levels of statistical
significance, reflecting a level of confidence in either evolutionary homology or functional
similarity. White boxes represent BLAST E values >1 × 10−6, indicating no or weak similarity;
light blue boxes represent E values in the range of 1 × 10−6 to 1 × 10−40; purple boxes represent
E values in the range of 1 × 10−40 to 1 × 10−100; and dark blue boxes represent E values <1 ×
10−100, indicating the highest degree of sequence conservation. Actual E values can be found
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in the Web supplement to this figure (62), where links to OMIM and GenBank may also be
found. A plus sign indicates our best estimate that the corresponding Drosophila gene product
is the functional equivalent of the human protein, based on degree of sequence similarity,
InterPro domain composition, and supporting biological evidence, when available. A minus
sign indicates that we were unable to identify a likely functional equivalent of the human
protein.
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Table 1
Numbers of distinct gene families versus numbers of predicted genes and their duplicated copies in H. influenzae, S.
cerevisiae, C. elegans, and D. melanogaster. Row one shows the total number of genes in each species. Row two shows
the total number of all genes in each genome that appear to have arisen by gene duplication. Row three is the total
number of distinct gene families for each genome. Each proteome was compared to itself using the same parameters
as described in (63).
H. influenzae S. cerevisiae C. elegans D. melanogaster
Total no. of predicted
genes
1709 6241 18424 13601
No. of genes duplicated 284 1858 8971 5536
Total no. of distinct
families
1425 4383 9453 8065
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Table 4
The 10 InterPro protein domains occurring in the largest number of different
proteins in S. cerevisiae and C. elegans.
Acc. no. InterPro domain name No. of proteins
S. cerevisiae
IPR000719 Eukaryotic protein kinase 119
IPR001680 G-protein beta WD-40 repeats 90
IPR001650 DNA/RNA helicase domain (DEAD/DEAH box) 75
IPR001138 Fungal transcriptional regulatory protein, N-terminus 60
IPR001042 TYA transposon protein 57
IPR000504 RNA-binding region RNP-1 (RNA recognition motif) 55
IPR001410 DEAD/DEAH box helicase 48
IPR000822 Zinc finger, C2H2 type 47
IPR001066 Sugar transporter 46
IPR001969 Eukaryotic and viral aspartyl proteases active site 42
C. elegans
IPR000168 7-Helix G-protein coupled receptor, nematode (probably olfactory) family 545
IPR000694 Proline-rich region 398
IPR000719 Eukaryotic protein kinase 388
IPR002356 G-protein–coupled receptors, rhodopsin family 335
IPR001628 C4-type steroid receptor zinc finger 224
IPR001810 F-box domain 215
IPR000087 Collagen triple helix repeat 166
IPR001304 C-type lectin domain 165
IPR002900 Domain of unknown function 142
IPR000822 Zinc finger, C2H2 type 138
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Table 5
Proteins in D. melanogaster, C. elegans, and S. cerevisiae with more than one InterPro domain. These numbers represent
the total number of recognizable domains within a single protein, no matter whether they are multiple copies of the
same domain or different domains.
InterPro domains per
protein
D. melanogaster
(number of proteins)
C. elegans
(number of proteins)
S. cerevisiae
(number of proteins)
2 920 1236 410
3 388 458 121
4 219 182 58
5 163 98 26
6 101 72 17
7 92 53 15
8 58 27 7
9 42 25 4
10 22 18 7
11–15 73 43 6
16–20 18 17 1
21–30 22 22 0
31–50 8 5 0
51–75 4 5 0
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Table 6
Proteins in D. melanogaster, C. elegans, and S. cerevisiae with multiple different InterPro domains. Individual InterPro
domains are counted only once per protein, regardless of how many times they occur in that protein.
Unique InterPro domains
per protein
D. melanogaster
(number of proteins)
C. elegans
(number of proteins)
S. cerevisiae
(number of proteins)
2 1474 1248 402
3 413 335 95
4 156 114 23
5 52 38 4
6 8 9 1
7 or more 4 3 0
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